Former Frier Levitt Chair, United Health and McKesson Chief, and federal and state prosecutors establish Health Law Alliance, a specialized healthcare boutique for government investigations, PBM audits, payor disputes, licensing board matters, and regulatory advice.
The firm’s founding partner, Anthony Mahajan, has decades of legal experience in healthcare, having been employed by a National Law Journal Top 20-ranked international law firm, the Department of Justice (DOJ) as an Assistant United States Attorney, McKesson Corp. as Chief Counsel and Vice President, United Health Group as Chief Compliance Officer, and most recently as Chair of Frier Levitt’s White Collar & Government Investigations practice.
In addition, the firm employs the former General Counsel of a publicly traded company, and former New York law firm corporate attorney to assist clients with corporate transactions and restructurings, a state prosecutor with extensive courtroom experience and jury trials, and Super Lawyer “Rising Stars” with experience defending entities throughout the healthcare delivery chain, including health systems, laboratories, pharmacies, physicians, MSOs, and individuals and investors, in criminal and civil matters and administrative proceedings.
As quoted in Law360, peers acknowledge our “more than two decades of crisis-management and extensive federal trial experience,” which provides clients with “strategic perspective and pragmatic solutions” as they “identify and manage risk, remediate significant instances of noncompliance, and respond to regulatory scrutiny.” In short, the firm’s mission is simple: use unmatched experience and insight to defend our clients against insurance conglomerates, the federal government, and state agencies. We used to work for them. Now let us fight for you. Contact us today for a consultation.
MORE ARTICLES BY CATEGORY
Resolving Prescription “Red Flags” Is No Longer Optional: Federal Scrutiny Tightens on Controlled-Substance Dispensing
Pharmacists must resolve “red flags” under the Controlled Substances Act’s corresponding-responsibility requirements before dispensing controlled substances. Overlooking warning signs, such as cash-paid, high-dose opioid prescriptions—can now trigger False Claims Act liability and massive penalties, as demonstrated by Walgreens’ $350 million settlement in April 2025.
Read More >>9th Circuit’s Landmark EKRA Ruling—What Providers Should Know
On July 11, 2025, the 9th Circuit upheld a laboratory operator’s convictions for violating EKRA by paying marketing agents to mislead providers into providing patient referrals for medically unnecessary blood tests. In this article, we analyze the 9th Circuit’s ruling and what it means for the future of EKRA enforcement.
Read More >>Collateral Consequences Mount Quickly After Adverse DEA Inspection
Adverse findings during a DEA inspection can trigger a chain reaction of serious consequences for pharmacies, including increasing fines, suspension or revocation of DEA registrations and pharmacy licenses, costly False Claims Act (FCA) lawsuits, and potential criminal liability.
Read More >>Heath Law Alliance Secures Reversal of a Medicaid Payment Suspension
Health Law Alliance successfully secured a full reversal of a Medi-Cal payment suspension for a California pharmacy, overturning speculative allegations made by the Department of Health Care Services. This case highlights the firm’s ability to protect healthcare providers against unjust enforcement actions and the critical value of experienced legal counsel in Medicaid and insurance disputes.
Read More >>